142 related articles for article (PubMed ID: 16042085)
1. Drug release from xyloglucan beads coated with Eudragit for oral drug delivery.
Yoo MK; Choi HK; Kim TH; Choi YJ; Akaike T; Shirakawa M; Cho CS
Arch Pharm Res; 2005 Jun; 28(6):736-42. PubMed ID: 16042085
[TBL] [Abstract][Full Text] [Related]
2. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of Eudragit S 100 microspheres as pH-sensitive release preparations for piroxicam and theophylline using the emulsion-solvent evaporation method.
Obeidat WM; Price JC
J Microencapsul; 2006 Mar; 23(2):195-202. PubMed ID: 16754375
[TBL] [Abstract][Full Text] [Related]
4. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
Rawat M; Saraf S; Saraf S
AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
[TBL] [Abstract][Full Text] [Related]
5. Preparation of ionic-crosslinked chitosan-based gel beads and effect of reaction conditions on drug release behaviors.
Chen S; Liu M; Jin S; Wang B
Int J Pharm; 2008 Feb; 349(1-2):180-7. PubMed ID: 17900834
[TBL] [Abstract][Full Text] [Related]
6. Core-shell particles formed by β-lactoglobulin microgel coated with xyloglucan.
Gtari W; Aschi A; Nicolai T; de Freitas RA
Int J Biol Macromol; 2016 Nov; 92():357-361. PubMed ID: 27426701
[TBL] [Abstract][Full Text] [Related]
7. Xanthan-alginate composite gel beads: molecular interaction and in vitro characterization.
Pongjanyakul T; Puttipipatkhachorn S
Int J Pharm; 2007 Feb; 331(1):61-71. PubMed ID: 17046185
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation and pharmacokinetics in dogs of guar gum and Eudragit FS30D-coated colon-targeted pellets of indomethacin.
Ji C; Xu H; Wu W
J Drug Target; 2007 Feb; 15(2):123-31. PubMed ID: 17365283
[TBL] [Abstract][Full Text] [Related]
9. Preparation and sustained release of diatomite incorporated and Eudragit L100 coated hydroxypropyl cellulose/chitosan aerogel microspheres.
Sang Y; Gao J; Han X; Liang T; Chen T; Zhao Y
Int J Biol Macromol; 2024 May; 267(Pt 1):131447. PubMed ID: 38588843
[TBL] [Abstract][Full Text] [Related]
10. Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis.
Ramasamy T; Ruttala HB; Shanmugam S; Umadevi SK
Drug Deliv; 2013 Feb; 20(2):65-77. PubMed ID: 23537465
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of matrices of Eudragit with polycarbophil and carbopol for colon-specific delivery.
Asghar LF; Chandran S
J Drug Target; 2008 Dec; 16(10):741-57. PubMed ID: 19005938
[TBL] [Abstract][Full Text] [Related]
12. Novel Pullulan-Eudragit® S100 blend microparticles for oral delivery of risedronate: formulation, in vitro evaluation and tableting of blend microparticles.
de Arce Velasquez A; Ferreira LM; Stangarlin MF; da Silva Cde B; Rolim CM; Cruz L
Mater Sci Eng C Mater Biol Appl; 2014 May; 38():212-7. PubMed ID: 24656371
[TBL] [Abstract][Full Text] [Related]
13. Thermally reversible xyloglucan gels as vehicles for rectal drug delivery.
Miyazaki S; Suisha F; Kawasaki N; Shirakawa M; Yamatoya K; Attwood D
J Control Release; 1998 Dec; 56(1-3):75-83. PubMed ID: 9801431
[TBL] [Abstract][Full Text] [Related]
14. Potential of calcium pectinate beads for target specific drug release to colon.
Jain A; Gupta Y; Jain SK
J Drug Target; 2007 May; 15(4):285-94. PubMed ID: 17487697
[TBL] [Abstract][Full Text] [Related]
15. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
[TBL] [Abstract][Full Text] [Related]
16. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G
Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650
[TBL] [Abstract][Full Text] [Related]
17. pH-sensitive release of indomethacin using lactan-acetate microspheres.
Na K; Lee KY
Drug Dev Ind Pharm; 1998 Jun; 24(6):563-8. PubMed ID: 9876624
[TBL] [Abstract][Full Text] [Related]
18. Mucoadhesive platforms for targeted delivery to the colon.
Varum FJ; Veiga F; Sousa JS; Basit AW
Int J Pharm; 2011 Nov; 420(1):11-9. PubMed ID: 21856393
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of pH modulated controlled release matrix systems for colon specific delivery of indomethacin.
Asghar LF; Chandran S
Pharmazie; 2008 Oct; 63(10):736-42. PubMed ID: 18972836
[TBL] [Abstract][Full Text] [Related]
20. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS
Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
